- Trials with a EudraCT protocol (1,894)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1,894 result(s) found for: Sexual partner.
Displaying page 1 of 95.
EudraCT Number: 2006-004397-27 | Sponsor Protocol Number: 310741 | Start Date*: 2007-10-19 | |||||||||||
Sponsor Name:Bayer Schering Pharma AG | |||||||||||||
Full Title: Multi-center, double-blind, placebo-controlled study to investigate the efficacy and safety of daily oral 100 mg dehydroepiandrosterone (DHEA) over 6 treatment cycles as a concomitant therapy to or... | |||||||||||||
Medical condition: Multi-center, double-blind, placebo-controlled study to investigate the efficacy and safety of daily oral 100 mg dehydroepiandrosterone (DHEA) over 6 treatment cycles as a concomitant therapy to or... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001966-40 | Sponsor Protocol Number: CD001 | Start Date*: 2014-01-27 | ||||||||||||||||
Sponsor Name:Companion Diagnostics BV | ||||||||||||||||||
Full Title: A double blind, randomized, placebo controlled, cross-over, Lybridos dose finding study to validate the predictive power of the diagnostic model for Lybrido and Lybridos efficacy and to identify an... | ||||||||||||||||||
Medical condition: Hypoactive Sexual Desire Disorder/SSRI-induced sexual dysfunction | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003543-30 | Sponsor Protocol Number: EB93 | Start Date*: 2012-08-24 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Emotional Brain BV | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: A double-blind, randomized, placebo-controlled, proof of concept study to investigate the differences between the combined administration of 0.5 mg sublingual testosterone and 10 mg buspirone and 1... | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Hypoactive Sexual Desire Disorder Sexual Interest/Arousal Disorder | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003343-74 | Sponsor Protocol Number: PDS234 | Start Date*: 2007-10-30 | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: A methodological investigation to test acute changes in female sexual desire in healthy volunteersand pre- and postmenopausal women diagnosed with hypoactive sexual desiredisordersusing explicit me... | |||||||||||||
Medical condition: hypoactive sexual desire disorder in women (HSDD) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002922-51 | Sponsor Protocol Number: H6D-MC-LVGH | Start Date*: 2006-10-16 | |||||||||||
Sponsor Name:Lilly ICOS LLC | |||||||||||||
Full Title: Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life | |||||||||||||
Medical condition: Erectile Dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000032-68 | Sponsor Protocol Number: 511.77 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG | |||||||||||||
Full Title: A Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy trial of Flibanserin 50 Milligrams Daily and 100 Milligrams Daily in premenopausal European Women With Hypoacti... | |||||||||||||
Medical condition: Primary generalized acquired Hypoactive Sexual Desire Disorder in Premenopausal women | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) NL (Completed) BE (Completed) ES (Completed) SE (Completed) HU (Completed) FI (Completed) CZ (Completed) AT (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000960-14 | Sponsor Protocol Number: FM57 | Start Date*: 2018-12-19 | ||||||||||||||||||||||||||
Sponsor Name:Futura Medical Developments Ltd. | ||||||||||||||||||||||||||||
Full Title: A Phase III, dose ranging, multi-centre, randomised, double blind, placebo controlled, home use, parallel group clinical trial of topically-applied glyceryl trinitrate (GTN) for the treatment of er... | ||||||||||||||||||||||||||||
Medical condition: Erectile dysfunction | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||||||||||||
Trial protocol: LV (Prematurely Ended) HU (Prematurely Ended) SK (Completed) PL (Prematurely Ended) CZ (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-000716-30 | Sponsor Protocol Number: RGL-003-001 | Start Date*: 2020-09-10 | |||||||||||
Sponsor Name:Gedeon Richter Plc. | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicenter, proof-of-concept study to evaluate a combined oral contraceptive (COC) containing 30 µg ethinylestradiol and 150 µg levonorgestrel plus ... | |||||||||||||
Medical condition: Hypoactive sexual desire disorder (HSDD) secondary to combined oral contraception use. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) BG (Completed) PL (Completed) CZ (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-007620-17 | Sponsor Protocol Number: PR3083 | Start Date*: 2008-02-19 | |||||||||||
Sponsor Name:Pantarhei Bioscience BV | |||||||||||||
Full Title: A double-blind, placebo-controlled, randomized, N=1 study to determine the effect of concomitant treatment with dehydroepiandrosterone (50 mg) on sexual functioning in 6 women who experience a decr... | |||||||||||||
Medical condition: Sexual dysfunction caused by the use of oral contraceptives | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001310-34 | Sponsor Protocol Number: OXY-COUP-PROT1.4 | Start Date*: 2011-08-11 |
Sponsor Name:Med. Univ. Wien, Univ. Klinik für Innere Med. III | ||
Full Title: Female Sexual Dysfunction in the Peri and Postmenopause: Effect of intranasal Oxytocin administration on sexual function and activity | ||
Medical condition: Sexual behaviour with reduced intercourse frequency due to female sexual function disorders | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-001179-39 | Sponsor Protocol Number: 2005108 | Start Date*: 2006-10-11 | |||||||||||
Sponsor Name:Procter & Gamble Pharmaceuticals | |||||||||||||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Parallel-group, Multicentre, 24 week Study to Evaluate the Efficacy and Safety of Transdermal Testosterone (300 mcg/day) in Naturally Menopausal Wome... | |||||||||||||
Medical condition: Hypoactive sexual desire disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002047-26 | Sponsor Protocol Number: FDC116115 | Start Date*: 2012-10-03 | ||||||||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | ||||||||||||||||||
Full Title: FDC116115: A prospective study of sexual function in sexually active men treated for BPH | ||||||||||||||||||
Medical condition: BPH (Benign prostatic hyperplasia) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: GR (Completed) NL (Completed) HU (Completed) ES (Completed) DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-001650-94 | Sponsor Protocol Number: 191622-133 | Start Date*: 2013-08-06 | |||||||||||
Sponsor Name:Allergan Limited | |||||||||||||
Full Title: An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation | |||||||||||||
Medical condition: Premature Ejaculation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011411-21 | Sponsor Protocol Number: BVF-324-302 | Start Date*: 2009-07-17 | |||||||||||
Sponsor Name:Biovail Laboratories International SRL, c/o Biovail Technologies Ltd | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Pre... | |||||||||||||
Medical condition: Premature Ejaculation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: HU (Prematurely Ended) BG (Prematurely Ended) CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011410-18 | Sponsor Protocol Number: BVF-324-301 | Start Date*: 2009-07-29 | |||||||||||
Sponsor Name:Biovail Laboratories International SRL, c/o Biovail Technologies Ltd | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Pre... | |||||||||||||
Medical condition: Premature Ejaculation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: BE (Completed) DE (Prematurely Ended) FR (Completed) SE (Prematurely Ended) ES (Completed) GB (Prematurely Ended) NL (Prematurely Ended) AT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004076-38 | Sponsor Protocol Number: 511.118 | Start Date*: 2007-11-30 | |||||||||||
Sponsor Name:Boehringer Ingelheim France | |||||||||||||
Full Title: A Twenty Eight –Week, Open-Label, Safety Study of Flibanserin 50 milligrams to 100 milligrams dailyin Premenopausal European Women With Hypoactive Sexual Desire Disorder | |||||||||||||
Medical condition: Primary generalized acquired Hypoactive Sexual Desire Disorder in Premenopausal women | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) NL (Completed) FI (Completed) BE (Completed) ES (Completed) CZ (Completed) SE (Completed) GB (Completed) AT (Prematurely Ended) HU (Completed) IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001228-37 | Sponsor Protocol Number: BAY38-9456/12146 | Start Date*: 2006-07-13 | |||||||||||
Sponsor Name:Bayer HealthCare AG, D-51368 Leverkusen | |||||||||||||
Full Title: A randomized, double blind, parallel group study of vardenafil flexible dose versus placebo in males with erectile dysfunction and their female partners’ sexual quality of life. PARTNER II | |||||||||||||
Medical condition: Males with Erectile Dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) ES (Completed) BE (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003171-39 | Sponsor Protocol Number: PSD502-PE-004 | Start Date*: 2007-12-07 | |||||||||||
Sponsor Name:Plethora Solutions Ltd | |||||||||||||
Full Title: A phase III, multi-centre, randomized, double-blind, placebo-controlled study, with open-label follow on, to evaluate the efficacy, safety and tolerability of PDS502 in subjects with Premature Ejac... | |||||||||||||
Medical condition: Premature Ejaculation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005571-89 | Sponsor Protocol Number: FM53 | Start Date*: 2015-06-22 | |||||||||||
Sponsor Name:Futura Medical Developments Ltd. | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, home use, cross-over clinical trial of topically-applied glyceryl trinitrate (GTN) for the treatment of Erectile Dysfunction | |||||||||||||
Medical condition: This study investigates a drug intended for the treatment of male patients self-diagnosed with Erectile Dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001055-21 | Sponsor Protocol Number: H6D-CR-S024 | Start Date*: 2008-07-30 | |||||||||||
Sponsor Name:Eli Lilly and Company Limited | |||||||||||||
Full Title: A Comparison of Psychosocial Outcomes Following Tadalafil Once a Day or PDE5 Inhibitor As Needed in Men With Erectile Dysfunction. | |||||||||||||
Medical condition: Erectile Dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
